Supplements That Help With Gallbladder Disease on Ozempic (Semaglutide)

At a glance

  • Ozempic label / Acute gallbladder disease is listed under warnings and precautions [1]
  • Label action / Gallbladder studies if cholelithiasis or cholecystitis are suspected [1]
  • Ozempic indication / Type 2 diabetes; no weight-loss indication [1]
  • GLP-1 class risk / Gallbladder disorders 26% more common than with control across 21 trials and 99,599 patients [2]
  • SELECT, semaglutide 2.4 mg / Gallbladder-related disorders 2.8% vs 2.3% on placebo [3]

The direct answer

No study of vitamin C, soluble fiber, omega-3 fatty acids, magnesium, lecithin or any other supplement for gallbladder disease in people taking semaglutide was identified, and the Ozempic label names no supplement.

The label's gallbladder entry is a diagnostic instruction: when cholelithiasis or cholecystitis are suspected, gallbladder studies are indicated [1].

What the Ozempic label says

Ozempic injection is approved to improve blood sugar in adults with type 2 diabetes, to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease [1]. Ozempic has no weight-loss indication [1].

Under warnings and precautions, the label lists acute gallbladder disease, and the action it gives is gallbladder studies if cholelithiasis or cholecystitis are suspected [1]. Cholecystitis and cholecystectomy also appear in the label's postmarketing reports, where frequency cannot be estimated [1].

How often gallbladder problems occur

A 2025 meta-analysis of 21 randomized trials covering 99,599 patients found gallbladder disorders 26% more common with GLP-1 receptor agonists than with control [2]. The SELECT trial used semaglutide 2.4 mg, above Ozempic's 2 mg maximum [1], in adults with established cardiovascular disease and overweight or obesity. It reported gallbladder-related disorders in 2.8% vs 2.3% on placebo, mainly cholelithiasis at 1.4% vs 1.1%; cholecystitis was 0.6% in both groups [3].

Frequently asked questions

What does the Ozempic label say to do if gallbladder disease is suspected?
It says gallbladder studies are indicated if cholelithiasis or cholecystitis are suspected [1].
Are gallbladder problems more common on semaglutide?
Across 21 trials of GLP-1 receptor agonists with 99,599 patients, gallbladder disorders were 26% more common than with control [2]. In SELECT with semaglutide 2.4 mg, gallbladder-related disorders were 2.8% vs 2.3% on placebo [3].

References

  1. U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
  2. Galli M, Benenati S, Laudani C, Simeone B, Sarto G, Ortega-Paz L, et al. Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients. J Am Coll Cardiol. 2025;86(20):1805-1819. Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients
  3. Kushner RF, Ryan DH, Deanfield J, Kokkinos A, Cercato C, Wilding J, et al. Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial. Obesity (Silver Spring). 2025;33(3):452-462. Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial
Evidence overview for Supplements That Help With Gallbladder Disease on Ozempic (Semaglutide)